scholarly journals Quality of life and treatment preference for ventricular assist device therapy in ambulatory advanced heart failure: A report from the REVIVAL study

2020 ◽  
Vol 39 (1) ◽  
pp. 27-36 ◽  
Author(s):  
Josef Stehlik ◽  
Maria Mountis ◽  
Donald Haas ◽  
Maryse Palardy ◽  
Amrut V. Ambardekar ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Ventricular Assist Device ◽  
Advanced Heart Failure ◽  
Treatment Preference ◽  
Device Therapy ◽  
Assist Device ◽  
Ventricular Assist

Preoperative Determinants of Quality of Life and Functional Capacity Response to Left Ventricular Assist Device Therapy

2016 ◽  
Vol 22 (10) ◽  
pp. 797-805 ◽  
Author(s):  
Michael S. Kiernan ◽  
Kartik S. Sundareswaran ◽  
Duc Thinh Pham ◽  
Navin K. Kapur ◽  
Naveen L. Pereira ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Functional Capacity ◽  
Left Ventricular Assist Device ◽  
Ventricular Assist Device ◽  
Left Ventricular ◽  
Device Therapy ◽  
Assist Device ◽  
Ventricular Assist ◽  
Left Ventricular Assist

Current Status of the Left Ventricular Assist Device as a Destination Therapy

2016 ◽  
Vol 10 (2) ◽  
pp. 1 ◽  
Author(s):  
Jorge Silva Enciso ◽  
Eric Adler ◽  
Barry Greenberg ◽  
◽  
Keyword(s):  
Heart Failure ◽  
Heart Transplantation ◽  
Left Ventricular Assist Device ◽  
Ventricular Assist Device ◽  
Left Ventricular ◽  
Advanced Heart Failure ◽  
Device Therapy ◽  
Assist Device ◽  
Ventricular Assist ◽  
Left Ventricular Assist

The heart failure epidemic has led to an increase in the number of patients with advanced heart failure, which is associated with high morbidity and mortality. Current therapies for advanced heart failure are limited to heart transplantation and mechanical circulatory support, with palliative care reserved for those ineligible to receive advanced therapies. Clinical trials of ventricular assist devices for patients with advanced heart failure demonstrate an improvement in survival and quality of life akin to heart transplantation. The Achilles heal of this therapy is the adverse event burden. Patient selection and multidisciplinary care are two of the strategies being used to improve long-term outcomes. Adjunct therapies in combination with left ventricular assist device therapy and advances in device technology in the near future may lessen the number of adverse events. This review summarizes the clinical outcomes, current challenges and future directions of left ventricular assist device therapy.

Sign in / Sign up

Export Citation Format

Share Document